<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>16</Volume>
				<Issue>15</Issue>
				<PubDate PubStatus="epublish">
					<Year>2015</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Whole Liver Palliative Radiotherapy for Patients with Massive Liver Metastases</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>6381</FirstPage>
			<LastPage>6384</LastPage>
			<ELocationID EIdType="pii">31422</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; The purpose of this retrospectively study was to examine the effectiveness and tolerability ofa radiotherapy technique for the palliation of symptomatic liver metastases. Materials and &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: Twentysevenpatients with liver metastases were enrolled and received targeted whole liver irradiation consisting ofmean 1, 8 Gy in five to twelve fractions to a total mean dose 17Gy. Symptoms at baseline were hepatic pain (26patients), lost of weight (6), lack of appetite (2), and night sweats (1). Seventeen patients (63%) had failed previoustreatment with chemotherapy and/or high-dose steroids. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Individual symptom response rates were 100%at 4 weeks. Partial or complete global symptomatic responses were noted in 11 patients (40%) after 2 months.After 3 months, 8 patients (28%) reported loss of pain. The treatment was well tolerated with one patient (3%)experiencing grade 3 toxicity (one vomiting and one diarrhoea). Overall the median survival time was 4.9 months(range 1 - 14 months). One year survival was 39%. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: This is simple and well-tolerated treatment butto achieve good palliation effects we should carefully selected patients whose conventional treatment does notbring good analgesic control.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">hepatic metastases</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">palliative radiotherapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">palliative treatment</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_31422_2cb34a752c1e994d7c50ba099ac753fa.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
